The Mount Sinai and Helsinki teams were led by Tao Xu, MD, Medical Director, Mount Sinai International (MSI); Jonathan Wetzel, MBA, Senior Director, MSI; and Sanna-Maria Kivivuori, MD, PhD, EMBA, Chief Quality Officer, Hospital District of Helsinki and Uusimaa (HUS). Top leaders not pictured are Szabi Dorotovics, MD, MBA, President, MSI; and Markku Mäkijärvi, MD, PhD, Chief Medical Officer, HUS.
Mount Sinai International (MSI) has entered into a collaborative relationship with the Hospital District of Helsinki and Uusimaa (HUS) in Helsinki, Finland. A 12-person team from Mount Sinai recently performed a week-long assessment of HUS facilities.
The initial focus is advising HUS on achieving Joint Commission International accreditation in six clinical areas (Anesthesia and Critical Care Medicine; Ophthalmology, Otorhinolaryngology, and Oral Surgery; Pediatrics; Obstetrics and Gynecology; Psychiatry; and Oncology).
HUS is a 17-hospital system that includes Helsinki University Hospital—one of the largest hospitals in Europe and the largest university hospital in Finland—which treats the nation’s most severe and rare illnesses.